Skip to main content

Loading market data...

EHC

Encompass Health Corporation

NYSE • United states

$121.67

-$0.04

(-0.03%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Management
Credibility
Score

Encompass Health Corporation (EHC)

Unavailable

Quotes may be delayed

$12.00B

Market Cap

1,385,437

Volume

19.3

P/E Ratio

0.65%

Div Yield

Encompass Health Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 9001 LIBERTY PARKWAY, BIRMINGHAM, AL
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Encompass Health Corporation.

13 Aug 2026

Encompass Health Corporation reported Another company event

Encompass Health Corporation filed an 8-K covering another company event.

7 Aug 2026

Encompass Health Corporation filed Form 10-Q

Encompass Health Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

Encompass Health Corporation reported Operating or financial results

Encompass Health Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

31 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Encompass Health Corporation.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$107.70M

Total assets (USD)$7.46B

Total liabilities (USD)$4.00B

Shareholders' equity (USD)$2.60B

Long-term debt (USD)$1.22B

Debt due within a year (USD)−$18.90M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.60B	Unavailable	$153.90M	$1.54	10-Q · 7 Aug 2026
Q1 2026	$1.59B	Unavailable	$194.50M	$1.93	10-Q · 1 May 2026
Q4 2025	$1.54B	Unavailable	$146.10M	Unavailable	10-K · 26 Feb 2026
Q3 2025	$1.48B	Unavailable	$126.50M	$1.24	10-Q · 31 Oct 2025
Q2 2025	$1.46B	Unavailable	$142.10M	$1.39	10-Q · 6 Aug 2025
Q1 2025	$1.46B	Unavailable	$151.50M	$1.48	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $146.78

20.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

10

⏸️

Hold

0

📉

Sell

0

10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 04:48 UTC Targets range 140.00–155.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

19

Oct 2026

Christie Edward M III

Director

Grant or award

$126.63 per share

221 shares

19

Oct 2026

Reidy Christopher R

Director

Grant or award

$126.89 per share

284 shares

15

Oct 2026

CARMICHAEL GREG D

Director

Grant or award

Unavailable per share

28 shares

15

Oct 2026

Williams Terrance

Director

Grant or award

Unavailable per share

28 shares

15

Oct 2026

SCHLICHTING NANCY M

Director

Grant or award

Unavailable per share

38 shares

15

Oct 2026

HERMAN JOAN E

Director

Grant or award

Unavailable per share

81 shares

15

Oct 2026

Christie Edward M III

Director

Grant or award

Unavailable per share

11 shares

15

Oct 2026

Reidy Christopher R

Director

Grant or award

Unavailable per share

20 shares

15

Oct 2026

Hayes Cain A

Director

Grant or award

Unavailable per share

4 shares

15

Oct 2026

O'Connor Kevin J.

Director

Grant or award

Unavailable per share

18 shares

Top Shareholders

Blackrock, Inc.

10,484,385 shares

-2.64% change

6/30/2026

Vanguard Group Inc

10,130,029 shares

-1.082% change

12/31/2025

Price T Rowe Associates Inc /Md/

5,055,801 shares

9.896% change

6/30/2026

Vanguard Portfolio Management Llc

4,924,664 shares

-0.703% change

6/30/2026

Vanguard Capital Management Llc

4,475,896 shares

0.216% change

6/30/2026

Wellington Management Group Llp

3,278,739 shares

-14.813% change

6/30/2026

State Street Corp

3,185,798 shares

1.298% change

6/30/2026

Citadel Advisors Llc

2,563,104 shares

400.717% change

6/30/2026

Alliancebernstein L.P.

2,471,751 shares

-5.703% change

6/30/2026

Fuller & Thaler Asset Management, Inc.

2,460,657 shares

10.344% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 04:48 UTC· 1 day ago

Research coverage and investment tools

Encompass Health Corporation (EHC) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Hospital/Nursing Management). Its last price was US$121.67 on 20 Oct 2026. That is 78% of the way from its 52-week low of US$92.77 to its 52-week high of US$129.96. It paid US$0.78 a share in dividends over the last 12 months, a dividend yield of 0.65%. The latest ex-dividend date on file is 1 Oct 2026. Its market capitalisation was US$12 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.60B	Unavailable	$153.90M	$1.54	—	—	—	10-Q · 7 Aug 2026 (opens in a new tab)
Q1 2026	$1.59B	Unavailable	$194.50M	$1.93	—	—	—	10-Q · 1 May 2026 (opens in a new tab)
Q4 2025	$1.54B	Unavailable	$146.10M	Unavailable	—	—	—	10-K · 26 Feb 2026 (opens in a new tab)
Q3 2025	$1.48B	Unavailable	$126.50M	$1.24	—	—	—	10-Q · 31 Oct 2025 (opens in a new tab)
Q2 2025	$1.46B	Unavailable	$142.10M	$1.39	—	—	—	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$1.46B	Unavailable	$151.50M	$1.48	—	—	—	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $107.70M
Total assets: $7.46B
Total liabilities: $4.00B
Shareholders' equity: $2.60B
Long-term debt: $1.22B
Debt due within a year: −$18.90M

SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Encompass Health Corporation.
8-K · 13 Aug 2026

Encompass Health Corporation reported Another company event (opens in a new tab)

Encompass Health Corporation filed an 8-K covering another company event.
10-Q · 7 Aug 2026

Encompass Health Corporation filed Form 10-Q (opens in a new tab)

Encompass Health Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 5 Aug 2026

Encompass Health Corporation reported Operating or financial results (opens in a new tab)

Encompass Health Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
SCHEDULE 13G/A · 31 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Encompass Health Corporation.

Insider	Date	Transaction	Shares	Average price	Filing
Christie Edward M III Director	19 Oct 2026	Grant or award (A)	+221	$126.63	Form 4 (opens in a new tab)
Reidy Christopher R Director	19 Oct 2026	Grant or award (A)	+284	$126.89	Form 4 (opens in a new tab)
CARMICHAEL GREG D Director	15 Oct 2026	Grant or award (A)	+28	—	Form 4 (opens in a new tab)
Williams Terrance Director	15 Oct 2026	Grant or award (A)	+28	—	Form 4 (opens in a new tab)
SCHLICHTING NANCY M Director	15 Oct 2026	Grant or award (A)	+38	—	Form 4 (opens in a new tab)
HERMAN JOAN E Director	15 Oct 2026	Grant or award (A)	+81	—	Form 4 (opens in a new tab)
Christie Edward M III Director	15 Oct 2026	Grant or award (A)	+11	—	Form 4 (opens in a new tab)
Reidy Christopher R Director	15 Oct 2026	Grant or award (A)	+20	—	Form 4 (opens in a new tab)
Hayes Cain A Director	15 Oct 2026	Grant or award (A)	+4	—	Form 4 (opens in a new tab)
O'Connor Kevin J. Director	15 Oct 2026	Grant or award (A)	+18	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	10,484,385	-2.64%
Vanguard Group Inc	12/31/2025	10,130,029	-1.082%
Price T Rowe Associates Inc /Md/	6/30/2026	5,055,801	9.896%
Vanguard Portfolio Management Llc	6/30/2026	4,924,664	-0.703%
Vanguard Capital Management Llc	6/30/2026	4,475,896	0.216%
Wellington Management Group Llp	6/30/2026	3,278,739	-14.813%
State Street Corp	6/30/2026	3,185,798	1.298%
Citadel Advisors Llc	6/30/2026	2,563,104	400.717%
Alliancebernstein L.P.	6/30/2026	2,471,751	-5.703%
Fuller & Thaler Asset Management, Inc.	6/30/2026	2,460,657	10.344%

Previous close: 121.71 USD
Day range: 119.77 – 123.45 USD
52-week range: 92.77 – 129.96 USD
Volume: 1,385,437
Market cap: $12.00B
Average volume: 637,943
P/E ratio: 19.3
EPS (FY 2025, diluted): 5.54 USD
Dividends (last 12 months): 0.78 USD
Dividend yield: 0.65%
Ex-dividend date: 1 Oct 2026
Shares outstanding: 98.65M
Beta (5Y monthly): 0.85

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 39 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 39 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for EHC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.